This site uses cookies to bring you the best experience. Find out more
Skip to main content

SECURITIES INFORMATION

 

NUMBER OF AIM SECURITIES IN ISSUE

As of 8 October 2019, the number of shares in issue was 207,189,337.
 

SIGNIFICANT SHAREHOLDERS

As of 8 October 2019, significant shareholdings in the share capital of Eden Research plc were:
 

Name

Number of shares

% of the issued ordinary share capital

Sipcam S.p.A.

20,494,330
 

9.89%

Gresham House Asset Management Limited

19,512,195
 

9.42%

HSBC Global Custody Nominee (UK) Limited

14,007,734

6.76%

J M Finn Nominees Limited

12,054,711

5.82%

Hargreaves Lansdown (Nominees) Limited

8,229,621
 

3.97%

Barclays Direct Investing Nominees Limited

7,935,746

3.83%

Interactive Investor Services Nominees Limited
SMKTNOMS

7,383,568
 

3.56%

The Bank of New York (Nominees) Limited

7,117,500
 

3.44%

Chase Nominees Limited ALPHAAIF

6,850,000

3.31%

Interactive Investor Services Nominees Limited 
SMKTISAS

6,521,171
 

3.15%

J M Finn Nominees Limited ISA

6,500,993

3.14%

 

DIRECTORS' SHAREHOLDINGS

Director

Number of shares

% of the issued ordinary share capital

A Abrey

1,152,824

0.56%

S Smith

433,393

0.21%

L van der Broek

358,500

0.17%

R Cridland

47,000

0.02%

 

SHARES NOT IN PUBLIC HANDS

In the terms of AIM Rules published July 2016 and insofar as it is aware, at 7 October 2019, 0.96% of the Company's AIM securities was not in public hands.

RESTRICTION IN TRANSFER OF AIM SECURITIES

There are no restrictions on the transfer of Eden Research Plc's AIM securities.

DETAILS OF ANY OTHER EXCHANGES AND TRADING PLATFORMS

Eden Research Plc has not applied or agreed to have any of it securities (including its AIM securities) admitted or traded on any other exchanges or trading platforms.

UK CITY CODE ON TAKEOVERS AND MERGERS

As an AIM traded UK registered company, Eden Research plc is subject to the UK City Code on Takeovers and Mergers legislation.